Navigation Links
EntreMed to Present at BioCentury Future Leaders in the Biotech Industry Conference
Date:3/25/2008

ROCKVILLE, Md., March 25 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that James S. Burns, President and Chief Executive Officer, will present a Corporate overview at the BioCentury Future Leaders in the Biotech Industry Conference, to be held at the Millennium Broadway Hotel & Conference Center, March 27, 2008. Mr. Burns' presentation is scheduled for Thursday, March 27, 2008 at 4:00 p.m. (local time).

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

Mr. Burns' live presentation will be web cast and can be accessed through the Company's web site at http://www.entremed.com. An archive will be available on the web site for approximately 90 days.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. MKC-1 is currently in multiple Phase 2 clinical trials for cancer. MKC-1 is an oral cell-cycle regulator with activity against the mTOR pathway. ENMD-1198, a novel antimitotic agent, is in a Phase 1 study in advanced cancer patients, and ENMD-2076, a selective kinase inhibitor, is expected to begin a Phase 1 study in 2Q08. The Company also has an approved IND application for Panzem(R) in rheumatoid arthritis. EntreMed's goal is to develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell-cycle regulation and inflammation -- processes vital to the treatment of cancer and other diseases,
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. EntreMed Announces 2008 Corporate and Clinical Program Priorities
2. EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results
3. EntreMed to Present at BIO CEO and Investor Conference
4. EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study
5. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
6. EntreMed Appoints Senior Vice President of Research and Development
7. EntreMed to Present at ThinkEquity Partners 5th Annual Growth Conference
8. Osteotech to Present at the Sidoti Conference in New York
9. BioMS Medical to present at BioCentury Conference
10. Biodel Inc. to Present at the BioCentury Future Leaders Conference on March 27th, 2008
11. Evotec AG: Fiscal Year 2007 Results Presentation on March 28, 2008 Live on the Internet

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., SAN DIEGO, Nov. 9 BioM...y that the company has received commitments from l...nsecured line of credit by $65 million to an aggre... terms of the facility. The weighted-average effe...t was 1.35% as of September 30, 2009. The maturity...
(Date:11/9/2009)..., SAN DIEGO, Nov. 9 NexBio, Inc. a...annual American College of Allergy, Asthma, and Im...entitled "DAS181 (Fludase®), a Sialidase, Dec...mmatory Effects in Animal Models of Asthma". ,,...oad spectrum host-targeting drug candidate being s...
(Date:11/9/2009)... Product release is a researc...jects, research facilities and research safety stu... , Cedar Knolls, NJ (PRWE...unced today that it has unveiled Pristima™ V...research facilities that track the use and care of...
(Date:11/8/2009)..., MOUNTAIN VIEW, Calif. Nov. 5, 2009 Complete...ing company, today announced publication of a repo...tary DNA sequencing platform, including analysis o... The consumables cost for these three genomes sequ...rays ranged from $8,005 for 87x coverage to $1,726...
Breaking Biology Technology:BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 2BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 3NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 3Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2
...of Wisconsin-Madison Medical School has a new hom...n, 160,600-square-foot building that will unify th...t of this is about creating the future of medicine...and graduate studies at UW Medical School. , ,The ...macy and physical therapy students in one facility...
... the Internet are no longer a pipe dream. That was...ntation, a panel discussion of Voice over Internet...e conversations over existing data networks has st...y Rocco, an IP telephony specialist with Cisco Sy...connected not to a phone jack but to an Ethernet p...
...a-ha!" hit the brains of some of the Internet,s ea...ew generation of Web browser tools designed to mak...ier than it is today. , ,At DEMO 2004, three compa...wing at the problem with tools that helped manage ...and his re-assembled team from the Allaire Softwar...
Other Biology Technology:UW Medical School to build Health Sciences Learning Center 2VoIP experts assess early implementations 2VoIP experts assess early implementations 3Plucking information from the web 2Plucking information from the web 3Plucking information from the web 4
(Date:11/4/2009)..., PHILADELPHIA Although scientists are reluctant...ntion method, evidence continues to grow about its...udy published in Cancer Prevention Research , a j...arch, which suggests some reduction in oral cancer...or of medicine in the Department of Thoracic/Head ...
(Date:11/4/2009)..., Heavy traffic corridors in the cities of Long B...nt proportion of preventable childhood asthma, and...ns on the disease has likely been underestimated, ...hern California (USC). , The study, which appea...f Public Health , estimated that nine percent of a...
(Date:11/4/2009)..., Vancouver, BC - Lowly bacteria, it turns out, h...ufacturing plants around the world clean up toxic ...ines, specifically RDX, were invented back in Worl...for decades. These high-energy compounds are ofte...owerful version of TNT. , But with increased k...
Breaking Biology News(10 mins):Does green tea prevent cancer? Evidence continues to brew, but questions remain 2USC study finds big air pollution impacts on local communities 2Genomic research will enable greener cleanup of military explosive test sites 2Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 1Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 2Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 3Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 4Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 5Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 6Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 7Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 8Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 9Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 10Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 11Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 12Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 13Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 14Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 15Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 16Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 17Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 18Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 19Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 20Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 21Frutarom Launches New Global Branding 5437 1Frutarom Launches New Global Branding 5437 2Frutarom Launches New Global Branding 5437 3Sangamo Announces Closing of Common Stock Offering 5433 1Sangamo Announces Closing of Common Stock Offering 5433 2Sangamo Announces Closing of Common Stock Offering 5433 3
...niversity,s Deborah A. Lange will receive a $900,0...e Environmental Protection Agency,s (EPA) Region I...d, Delaware, West Virginia and the District of Col... economic use of brownfields. Brownfields are aban...ial properties. The money, slated for allocation o...
...ity will award the 2008 Louisa Gross Horwitz Prize...of the Department of Cellular Biochemistry at the ...nd Arthur Horwich, M.D., Eugene Higgins Professor ...Hughes Medical Institute (HHMI) investigator at Ya...orative work in expanding fundamental understandin...
...ating predators to fight a superweed spreading thr...let, says a world expert on Japanese knotweed at t...he Department of Biology has been researching the ...ues with PhD students Michelle Hollingsworth and C...rtment established that the weed in Britain was a ...
Other Biology News:Columbia to award 2008 Horwitz Prize to Arthur Horwich & Ulrich Hartl for cellular protein folding 2Columbia to award 2008 Horwitz Prize to Arthur Horwich & Ulrich Hartl for cellular protein folding 3Columbia to award 2008 Horwitz Prize to Arthur Horwich & Ulrich Hartl for cellular protein folding 4'Plant-eating predator to fight superweed is not magic bullet' 2
...ay (3 per pack), 1. One system for gel staining a... Blue or silver-stain gels for proteins and nuclei...y ECL detection and chromogenic detection.Programm...ocessing time.Proven design for consistent, high-q...
Goat Anti-Human PARAINFLUENZA VIRUS 2+3 Polyclonal Antibody, Unconjugated from AbD Serotec
Cary 50 Microplate Reader Accessory from Varian, Inc.
IMAGEQUANT 300 WKSTN from GE Healthcare, formerly Amersham Biosciences
Biology Products: